Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · January 07, 2025

Effects of Treatment With Botulinum Toxin Type A on Clinical and Biophysical Parameters in Patients With Erythematotelangiectatic Rosacea

Dermatologic Surgery

 

Additional Info

Dermatologic Surgery
Effects of Botulinum Toxin Type A Treatment on Clinical and Biophysical Parameters in Patients With Erythematotelangiectatic Rosacea: A Prospective, Randomized, Controlled, Double-Blind Study
Dermatol Surg 2024 Dec 16;[EPub Ahead of Print], BB Dağtaş, O Erdem, Tİ Güneç, EB Avcı, V Manav, AE Koku Aksu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading